HY-101056-10mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
HY-101056-100mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
HY-101056-5mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
HY-101056-50mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
HY-103226-10mg
|
MedChemexpress LLC
|
SC-57461A [CAS 423169-68-0]
|
|
COVID-19-immunoregulation
|
|
HY-103226-100mg
|
MedChemexpress LLC
|
SC-57461A [CAS 423169-68-0]
|
|
COVID-19-immunoregulation
|
|
HY-103226-25mg
|
MedChemexpress LLC
|
SC-57461A [CAS 423169-68-0]
|
|
COVID-19-immunoregulation
|
|
HY-103226-5mg
|
MedChemexpress LLC
|
SC-57461A [CAS 423169-68-0]
|
|
COVID-19-immunoregulation
|
|
HY-103226-50mg
|
MedChemexpress LLC
|
SC-57461A [CAS 423169-68-0]
|
|
COVID-19-immunoregulation
|
|
HY-103364-1mg
|
MedChemexpress LLC
|
C-021 [CAS 864289-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-103364-10mg
|
MedChemexpress LLC
|
C-021 [CAS 864289-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-103364-100mg
|
MedChemexpress LLC
|
C-021 [CAS 864289-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-103364-25mg
|
MedChemexpress LLC
|
C-021 [CAS 864289-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-103364-5mg
|
MedChemexpress LLC
|
C-021 [CAS 864289-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-103364-50mg
|
MedChemexpress LLC
|
C-021 [CAS 864289-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-103370-1mg
|
MedChemexpress LLC
|
Talniflumate [CAS 66898-62-2]
|
|
COVID-19-immunoregulation
|
|
HY-103370-10mg
|
MedChemexpress LLC
|
Talniflumate [CAS 66898-62-2]
|
|
COVID-19-immunoregulation
|
|
HY-103370-5mg
|
MedChemexpress LLC
|
Talniflumate [CAS 66898-62-2]
|
|
COVID-19-immunoregulation
|
|
HY-103370-50mg
|
MedChemexpress LLC
|
Talniflumate [CAS 66898-62-2]
|
|
COVID-19-immunoregulation
|
|
HY-103637A-1mg
|
MedChemexpress LLC
|
Vimirogant (hydrochloride) [CAS 1802678-42-7]
|
|
COVID-19-immunoregulation
|
|
HY-103637A-10mg
|
MedChemexpress LLC
|
Vimirogant (hydrochloride) [CAS 1802678-42-7]
|
|
COVID-19-immunoregulation
|
|
HY-103637A-5mg
|
MedChemexpress LLC
|
Vimirogant (hydrochloride) [CAS 1802678-42-7]
|
|
COVID-19-immunoregulation
|
|
HY-10418-10mg
|
MedChemexpress LLC
|
AH 6809 [CAS 33458-93-4]
|
|
COVID-19-immunoregulation
|
|
HY-10418-100mg
|
MedChemexpress LLC
|
AH 6809 [CAS 33458-93-4]
|
|
COVID-19-immunoregulation
|
|
HY-10418-5mg
|
MedChemexpress LLC
|
AH 6809 [CAS 33458-93-4]
|
|
COVID-19-immunoregulation
|
|